Advances in Stimuli-Responsive Smart Drug Delivery Systems: A Systematic Review

Year : 2026 | Volume : 13 | 02 | Page :
    By

    Sanjana Dinesh Lanjewar,

  • Prajakta Chandrashekhar Dukre,

  • Sangharsh Dinesh Lanjewar,

  • Pravin Suruse,

  1. Student, Department of Pharmacy, Nagpur College of Pharmacy, Wanadongri, Hingna road, Nagpur -441110, Maharashtra, India
  2. Student, Department of Pharmacy, Nagpur College of Pharmacy, Wanadongri, Hingna road, Nagpur -441110, Maharashtra, India
  3. Assistant Professor, Department of Pharmacy, National College of Pharmacy, Behind Ujjawal Nagar, Somalwada, Nagpur-440015, Maharashtra, India
  4. Student, Department of Pharmacy, Nagpur College of Pharmacy, Wanadongri, Hingna road, Nagpur -441110, Maharashtra, India

Abstract

Imagine a world where medicines work smarter, not harder. Stimuli-responsive drug delivery systems (SRDDS) are transforming healthcare by releasing therapeutic agents in response to specific triggers. These triggers can be internal, like changes in pH or temperature, or external, like light or magnetic fields. By leveraging these triggers, SRDDS can optimize treatment and minimize side effects. The potential applications of SRDDS are vast, from cancer treatment to gene delivery and tissue engineering. Researchers are exploring ways to develop advanced materials and technologies to improve these systems. By integrating SRDDS with cutting-edge technologies like artificial intelligence and machine learning, we can enhance their precision and effectiveness. Personalized SRDDS could revolutionize patient care by enabling tailored treatment strategies that cater to individual needs. As research advances, SRDDS will likely play a crucial role in shaping the future of medicine. These systems have the potential to improve treatment outcomes, reduce healthcare costs, and enhance quality of life. By harnessing the power of SRDDS, we can unlock new opportunities for improving human health and transforming the pharmaceutical landscape. With ongoing research, SRDDS will continue to evolve and become a vital component of modern medicine, enabling precise and efficient treatment of various diseases. The future of SRDDS is promising, and its impact on patient care will be significant, very soon now too.

Keywords: Stimuli-responsive drug delivery, Targeted therapy, Personalized medicine, Advanced drug delivery systems, Smart medicine, Precision medicine, Controlled release technology

How to cite this article:
Sanjana Dinesh Lanjewar, Prajakta Chandrashekhar Dukre, Sangharsh Dinesh Lanjewar, Pravin Suruse. Advances in Stimuli-Responsive Smart Drug Delivery Systems: A Systematic Review. Trends in Drug Delivery. 2026; 13(02):-.
How to cite this URL:
Sanjana Dinesh Lanjewar, Prajakta Chandrashekhar Dukre, Sangharsh Dinesh Lanjewar, Pravin Suruse. Advances in Stimuli-Responsive Smart Drug Delivery Systems: A Systematic Review. Trends in Drug Delivery. 2026; 13(02):-. Available from: https://journals.stmjournals.com/tdd/article=2026/view=246012


References

1. Aszad Alam, R. K. (2023). Nanofiber-Based Systems for Stimuli-Responsive and Dual Drug Delivery: Present Scenario and the Way Forward. ACS Biomaterials Science & Engineering, 9(6), 3160-3184. doi:10.1021/acsbiomaterials.3c00363
2. Cai, J., Jiang, Y., Lin, L., Zhang, H., Guo, X., Yang, Q., . . . Xu, S. (2020). Ultrasound-responsive materials for drug/gene delivery. Journal of Controlled Release, 324, 138-150. doi:10.1016/j.jconrel.2020.05.036
3. Chen, M., Wang, J., & Yang, Y. (2020). Light-triggered drug delivery systems based on photolabile linkers and photodynamic therapy platforms. Journal of Controlled Release, 326, 482-495. doi:10.1016/j.jconrel.2020.07.025
4. Chen, X. &. (2019). Glucose-responsive hydrogels for diabetes management. Journal of Diabetes Science and Technology,, 13(3), 532-541. doi:10.1177/1932296818823448
5. Duan, X., Xiao, J., Yin, Q., Zhang, Z., Yu, H., Mao, S., & Li, Y. (2013). Redox-responsive, core cross linked micelles capable of on demand, concurrent drug release and structure disassembly. Biomacromolecules, 14(10), 3706-3712. doi:10.1021/bm401048z
6. Gao, W. &. (2020). stimuli responsive drug delivery system for cancer. journal of controlled release 324, 123-134. doi:10.1016/j.jconrel.2020.05.016
7. Kanamala, M., Wilson, W. R., Yang, M., Palmer, B. D., & Wu, Z. (2016). Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review. Biomaterials, 85, 152-167. doi:https://doi.org/10.1016/j.biomaterials.2016.01.012
8. Khan, M. U., Raza, F., Khan, M. W., Khan, R. A., Raza, A., Khan, A., & Ullah, A. (2023). Recent progress in thermosensitive hydrogels and their applications in drug delivery area. MedComm – Biomaterials and Applications, 2, e55. doi:10.1002/mba2.55
9. Kocak, G., Tuncer, C., & Bütün, V. (2017). pH-responsive polymers. Polymer Chemistry, 8(1), 144-176. doi:10.1039/C6PY01872F
10. Li Zhou, T. Z. (2025). Stimuli-responsive peptide-based nanodrug delivery systems for tumor therapy. Chemical Communications, 61(41), 7384-7407. doi:10.1039/D5CC00950B
11. lie, L. J. (2020). Advances in stimuli-responsive drug delivery systems. Advanced Healthcare Materials, 9(15), 45. doi:10.1002/adhm.202000645
12. Liu, J. F., Jang, B. J., Issadore, D., & Tsourkas, A. (2019). Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 11(6): e1571. doi:10.1002/wnan.1571
13. Liu, J., Yu, H., Wang, L., Shen, D., & Teng, L. (2020). Recent progress in design and preparation of glucose-responsive insulin delivery systems. Journal of Controlled Release, 321, 236-258. doi:10.1016/j.jconrel.2020.02.014
14. Liu, Y. &. (2018). Stimuli-responsive hydrogels for biomedical applications. Biomaterials, 163, 104-115. doi:10.1016/j.biomaterials.2018.02.004
15. Song, C., Niu, L., Lin, Y., Wang, Y., & Gong, C. (2022). Hypoxia-responsive nanocarriers in cancer therapy: A review of recent advances. Acta Pharmaceutica Sinica B, 12, 3040-3060. doi:10.1016/j.apsb.2022.01.007
16. Tao Wang, C. W. (2023). Stimuli-responsive nanocarrier delivery systems for Pt-based antitumor complexes: a review. RSC Advances, 16488-16511. doi:10.1039/D3RA00866E
17. Wang, Y. &. (2018). Biomedical applications of stimuli-responsive hydrogels. Biomaterials Science,, 6(10), 2536-2545. doi:10.1039/C8BM00642A
18. Wang, Y. &. (2020). pH-responsive nanoparticles for cancer therapy. Journal of Nanoparticle Research, 22(10), 273-285. doi:10.1007/s11051-020-05014-4
19. Zhang, Y. &. (2019). stimuli responsive nanoparticle for targeted drug delivery system. advance drug delivery review 143, 34-46.
20. Zhang, Y. &. (2020). Multi-stimuli responsive drug delivery systems for cancer therapy. Journal of Controlled Release, 325, 145-155. doi:10.1016/j.jconrel.2020.06.028
21. Zhao, X., Xi, Y., Zhang, Y., Wu, Q., Meng, R., Zheng, B., & Rei, L. (2019). Redox-sensitive gelatin/silica-aptamer nanogels for targeted siRNA delivery. Nanoscale Research Letters, 14, 273-281. doi:10.1186/s11671-019-3092-2
22. Zou, J., Zhang, F., Zhang, S., Pollack, S. F., Elsabahy, M., Fan, J., & Wooley, K. L. (2014). Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery. Advanced Healthcare Materials, 3(3), 441-448. doi:10.1002/adhm.201300304

Ahead of Print Subscription Review Article
Volume 13
02
Received 17/05/2026
Accepted 03/06/2026
Published 04/06/2026
Publication Time 18 Days
1

Login


My IP

PlumX Metrics